about
Unusual manifestation of diarrhea-associated haemolytic uraemic syndrome in an adult.In a retrospective international study, circulating miR-148b and let-7b were found to be serum markers for detecting primary IgA nephropathy.Th1, Th2 and Treg/T17 cytokines in two types of proliferative glomerulonephritis.Impact of Τh1 and Τh2 cytokines in the progression of idiopathic nephrotic syndrome due to focal segmental glomerulosclerosis and minimal change disease.Treatment of severe IgA nephropathy with omega-3 fatty acids: the effect of a "very low dose" regimen.C5b-9 glomerular deposition and tubular alpha3beta1-integrin expression are implicated in the development of chronic lesions and predict renal function outcome in immunoglobulin A nephropathy.IgA nephropathy in Greece: data from the registry of the Hellenic Society of Nephrology.Functional analysis of a novel GATA3 mutation in a family with the hypoparathyroidism, deafness, and renal dysplasia syndrome.Detection of multiple cytokines in the urine of patients with focal necrotising glomerulonephritis may predict short and long term outcome of renal function.Adult-onset idiopathic nephrotic syndrome associated with pure diffuse mesangial hypercellularityFactors influencing the course and the response to treatment in primary focal segmental glomerulosclerosisEffect of IL-11 on glomerular expression of TGF-beta and extracellular matrix in nephrotoxic nephritis in Wistar Kyoto ratsInfluence of aldosterone synthase gene C-344T polymorphism on focal segmental glomerulosclerosisNew insights of osmoregulatory system changes in ovarian hyperstimulation syndromeHistological grading in primary membranous nephropathy is essential for clinical management and predicts outcome of patientsImmunosuppressive regimens based on Cyclophospamide or Calcineurin inhibitors: Comparison of their effect in the long term outcome of Primary Membranous Nephropathy
P50
Q33379008-B5546088-53EF-4AFA-90F5-27BB8F907C70Q41115743-CDA627B0-D617-4ACC-A324-77379BC85DAEQ41269620-6738E746-CD38-4160-91FD-0F0E64C7ECADQ42361928-702BD8BD-6CA7-417C-A4BD-E8E3B73E08E8Q45088515-3C18EF8A-4C55-4399-A628-6ADF86E7EA6CQ46217075-5E628A83-A0D7-466A-9A76-8F7742BADD3BQ49477908-576379A0-6910-49CC-A904-C4227DA8FA6CQ50474860-F5C39C7A-8EE3-4032-B0F1-586C16296ECAQ51504182-20412B7A-B80B-40E5-8F13-AA95982245DDQ73914322-9F5462D7-AE17-42BD-A69A-58D8780B0973Q74291192-DFA72F4E-190D-4EE9-9A66-FC10AF2B750DQ84577622-A7003168-BE48-4AD6-A1DF-0A09745E9096Q84581631-DB676AD8-7F1E-44D2-8BC8-3C84F5080BEFQ85047200-85F04563-D984-427D-801C-450A8A50BB75Q91986622-323085C2-73B0-45ED-9671-023E62B7C013Q92564102-DF4C96D8-8E41-484C-9788-3D475238DDF1
P50
description
researcher ORCID ID = 0000-0003-2496-9863
@en
wetenschapper
@nl
name
Maria Stangou
@ast
Maria Stangou
@en
Maria Stangou
@es
Maria Stangou
@nl
type
label
Maria Stangou
@ast
Maria Stangou
@en
Maria Stangou
@es
Maria Stangou
@nl
prefLabel
Maria Stangou
@ast
Maria Stangou
@en
Maria Stangou
@es
Maria Stangou
@nl
P106
P1153
6507348994
P21
P31
P496
0000-0003-2496-9863